<DOC>
	<DOC>NCT01411696</DOC>
	<brief_summary>This is a retrospective data collection study to evaluate the efficacy, safety, and re-injection interval of OZURDEX速 in the treatment of macular edema due to RVO. Following informed consent, there were no patient study visits. All data was collected via chart review.</brief_summary>
	<brief_title>Retrospective Study in Patients Receiving Two or More OZURDEX速 Injections for Retinal Vein Occlusion (RVO)</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Macular edema Received at least 2 OZURDEX速 injections Received OZURDEX速 injections as part of a clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>